methylprednisolone has been researched along with Allergic Encephalomyelitis in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (16.13) | 18.7374 |
| 1990's | 2 (6.45) | 18.2507 |
| 2000's | 10 (32.26) | 29.6817 |
| 2010's | 12 (38.71) | 24.3611 |
| 2020's | 2 (6.45) | 2.80 |
| Authors | Studies |
|---|---|
| Bárcena, B; Besedovsky, HO; Espinosa, A; Fragoso, G; Meneses, G; Peón, AN; Pérez-Osorio, IN; Rassy, D; Sciutto, E; Terrazas, LI | 1 |
| Li, G; Li, H; Ma, Z; Wang, M; Wang, XY; Wang, Z; Yi, H; Zheng, G | 1 |
| Dokoohaki, S; Farhadi, N; Ghanbari, A; Ghareghani, M; Sadeghi, H; Zibara, K | 1 |
| Jeun, SS; Kim, MJ; Kim, WS; Lim, JY; Park, SA; Park, SI; Ryu, CH | 1 |
| Blaževski, J; Jevtic, B; Miljković, D; Momčilović, M; Mostarica Stojković, M; Petković, F | 1 |
| Dai, YQ; Hu, XQ; Lu, ZQ; Qiu, W; Ruan, HF; Shu, YQ; Wang, YG; Wu, AM; Xiao, L; Yang, Y | 1 |
| Bi, J; Liu, Z; Wang, C; Wang, P; Xie, Z; You, W; Zhu, Z | 1 |
| Appeldoorn, CC; Gaillard, PJ; Gladdines, W; Lee, DH; Linker, RA; Reijerkerk, A; Rötger, C | 1 |
| Dokoohaki, S; Farhadi, N; Ghanbari, A; Ghareghani, M; Hosseini, SM; Mohammadi, R; Sadeghi, H | 1 |
| Bähr, M; Graf, I; Hein, K; Herold, S; Jung, K; Kumar, P; Menkhoff, H; Schulz, X | 1 |
| Alderuccio, F; Ban, EJ; Bernard, C; Chan, J; Chun, KH; McQualter, J; Toh, BH; Wang, S | 1 |
| Dutt, M; Rostami, A; Shindler, KS; Tabuena, P; Ventura, E | 1 |
| Miljković, D; Miljković, Z; Momcilović, M; Mostarica-Stojković, M | 1 |
| Chen, X; Hu, X; Jiang, Y; Liu, M; Liu, Y; Ma, X; Mao, X; Pi, R | 1 |
| Hong, MF; Huang, YQ; Jie, A; Peng, ZX; Su, QX; Wang, R; Wang, XH; Wei, ZS; Yu, QY; Zhang, MX | 1 |
| Appeldoorn, CC; de Vries, HE; Dorland, R; Gaillard, PJ; Kooij, G; Reijerkerk, A; Rip, J; van der Pol, SM | 1 |
| Bähr, M; Diem, R; Hobom, M; Maier, K; Meyer, R; Storch, MK; Weissert, R | 1 |
| KIBLER, RF | 2 |
| Butovsky, O; Hauben, E; Ibarra, A; Schwartz, M | 1 |
| Bähr, M; Demmer, I; Diem, R; Ehrenreich, H; Maier, K; Merkler, D; Sättler, MB; Stadelmann, C | 1 |
| Becker, G; Briel, A; Gold, R; Hauff, P; Linker, RA; Mäurer, M; Reinhardt, M; Rieckmann, P; Schirner, M; Toyka, KV | 1 |
| Bendszus, M; Briel, A; Hauff, P; Ladewig, G; Linker, RA; Mäurer, M; Reinhardt, M; Schirner, M | 1 |
| Gold, R; Knauth, M; Linker, RA; Lühder, F; Metselaar, JM; Mohr, A; Schmidt, J; Weller, C | 1 |
| Dijkstra, CD; Polman, CH; Sontrop, K; Uitdehaag, BM | 1 |
| Gold, R; Hartung, HP; Schmidt, J; Schönrock, L; Toyka, KV; Zettl, UK | 1 |
| Gold, R; Schmidt, J; Stürzebecher, S; Toyka, KV | 1 |
| Abramsky, O; Brenner, T; Mizrachi-Kol, R; Steiner, I | 1 |
| Kowalczyk-Bronisz, SH | 1 |
| Kibler, RF; Paty, DW; Vogel, C | 1 |
| Abrahamson, HA | 1 |
31 other study(ies) available for methylprednisolone and Allergic Encephalomyelitis
| Article | Year |
|---|---|
Intranasal Methylprednisolone Effectively Reduces Neuroinflammation in Mice With Experimental Autoimmune Encephalitis.
Topics: Administration, Intranasal; Animals; Anti-Inflammatory Agents; Encephalitis; Encephalomyelitis, Autoimmune, Experimental; Female; Inflammation Mediators; Lymphocytes; Macrophages; Methylprednisolone; Mice, Inbred C57BL; Microglia; Spinal Cord | 2020 |
Methylprednisolone alleviates multiple sclerosis by expanding myeloid-derived suppressor cells via glucocorticoid receptor β and S100A8/9 up-regulation.
Topics: Animals; Arginase; Biomarkers; Calgranulin A; Calgranulin B; Disease Models, Animal; Disease Susceptibility; Encephalomyelitis, Autoimmune, Experimental; Flow Cytometry; Humans; Immunophenotyping; Leukocytes, Mononuclear; Methylprednisolone; Mice; Multiple Sclerosis; Myeloid-Derived Suppressor Cells; Receptors, Glucocorticoid; T-Lymphocytes | 2020 |
Corticosteroid therapy exacerbates the reduction of melatonin in multiple sclerosis.
Topics: Adrenal Cortex Hormones; Animals; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Humans; Interferon-gamma; Interleukin-4; Melatonin; Methylprednisolone; Multiple Sclerosis; Rats; Th1 Cells; Th2 Cells | 2017 |
Effective combination of methylprednisolone and interferon β-secreting mesenchymal stem cells in a model of multiple sclerosis.
Topics: Animals; Anti-Inflammatory Agents; Encephalomyelitis, Autoimmune, Experimental; Female; Genetic Therapy; Humans; Interferon-beta; Mesenchymal Stem Cell Transplantation; Methylprednisolone; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Spinal Cord | 2018 |
High interleukin-10 expression within the central nervous system may be important for initiation of recovery of Dark Agouti rats from experimental autoimmune encephalomyelitis.
Topics: Animals; Astrocytes; Cells, Cultured; Chemokine CXCL12; Convalescence; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Gene Expression Regulation; Interleukin-10; Methylprednisolone; Rats; Rats, Inbred Strains; Spinal Cord; Transforming Growth Factor beta | 2013 |
Combined therapy with methylprednisolone and ulinastatin in experimental autoimmune encephalomyelitis.
Topics: Animals; Drug Combinations; Encephalomyelitis, Autoimmune, Experimental; Female; Glycoproteins; Methylprednisolone; Mice; Mice, Inbred C57BL; Multiple Sclerosis | 2013 |
Mycophenolate mofetil improves neurological function and alters blood T-lymphocyte subsets in rats with experimental autoimmune encephalomyelitis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Enzyme Inhibitors; Female; Guinea Pigs; Immunosuppressive Agents; IMP Dehydrogenase; Interleukin-2 Receptor alpha Subunit; Leukocyte Common Antigens; Lymphocyte Count; Methylprednisolone; Multiple Sclerosis; Mycophenolic Acid; Random Allocation; Rats; Rats, Wistar; T-Lymphocyte Subsets | 2014 |
Glutathione PEGylated liposomal methylprednisolone (2B3-201) attenuates CNS inflammation and degeneration in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis.
Topics: Animals; Astrocytes; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Liposomes; Macrophages; Methylprednisolone; Mice; Mice, Inbred C57BL; Multiple Sclerosis, Relapsing-Remitting; Myelin-Oligodendrocyte Glycoprotein; Polyethylene Glycols; Spinal Cord; T-Lymphocytes | 2014 |
Methylprednisolone improves lactate metabolism through reduction of elevated serum lactate in rat model of multiple sclerosis.
Topics: Animals; Anti-Inflammatory Agents; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Guinea Pigs; Lactic Acid; Methylprednisolone; Multiple Sclerosis; Rats; Rats, Inbred Lew | 2016 |
CatWalk gait analysis in a rat model of multiple sclerosis.
Topics: Animals; Anti-Inflammatory Agents; Area Under Curve; Automation, Laboratory; Biomechanical Phenomena; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Female; Functional Laterality; Gait; Immunohistochemistry; Logistic Models; Methylprednisolone; Random Allocation; Rats; Spinal Cord | 2016 |
Methylprednisolone induces reversible clinical and pathological remission and loss of lymphocyte reactivity to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis.
Topics: Animals; Anti-Inflammatory Agents; Brain; Cell Proliferation; Cells, Cultured; Encephalomyelitis, Autoimmune, Experimental; Female; Lymphocyte Activation; Methylprednisolone; Mice; Mice, Inbred C57BL; Myelin Proteins; Myelin-Associated Glycoprotein; Myelin-Oligodendrocyte Glycoprotein; Remission Induction; Spinal Cord | 2008 |
Timing of corticosteroid therapy is critical to prevent retinal ganglion cell loss in experimental optic neuritis.
Topics: Animals; Cell Count; Cell Survival; Dexamethasone; Encephalomyelitis, Autoimmune, Experimental; Female; Fluorescent Dyes; Glucocorticoids; Methylprednisolone; Mice; Optic Neuritis; Retinal Ganglion Cells; Stilbamidines; Time Factors | 2010 |
Methylprednisolone inhibits IFN-gamma and IL-17 expression and production by cells infiltrating central nervous system in experimental autoimmune encephalomyelitis.
Topics: Animals; Antigens, CD; Central Nervous System; Encephalomyelitis, Autoimmune, Experimental; Glucocorticoids; Hormone Antagonists; Interferon-gamma; Interleukin-17; Methylprednisolone; Mifepristone; Rats; Rats, Inbred Strains; Receptors, Glucocorticoid | 2009 |
Combination of methylprednisolone and minocycline synergistically improves experimental autoimmune encephalomyelitis in C57 BL/6 mice.
Topics: Analysis of Variance; Animals; Anti-Bacterial Agents; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Encephalomyelitis, Autoimmune, Experimental; Enzyme-Linked Immunosorbent Assay; Female; Freund's Adjuvant; Glycoproteins; Interferon-gamma; Interleukin-4; Methylprednisolone; Mice; Mice, Inbred C57BL; Minocycline; Myelin-Oligodendrocyte Glycoprotein; Nerve Growth Factor; Neuroprotective Agents; Peptide Fragments; RNA, Messenger | 2010 |
Super-high-dose methylprednisolone does not improve efficacy or induce glucocorticoid resistance in experimental allergic encephalomyelitis.
Topics: Animals; Cytokines; Dose-Response Relationship, Drug; Dose-Response Relationship, Immunologic; Drug Resistance; Encephalomyelitis, Autoimmune, Experimental; Female; Guinea Pigs; Male; Methylprednisolone; Nuclear Proteins; Protein Isoforms; Rats; Rats, Wistar; Receptors, Glucocorticoid; RNA-Binding Proteins; Serine-Arginine Splicing Factors; Treatment Outcome | 2011 |
Enhanced brain delivery of liposomal methylprednisolone improved therapeutic efficacy in a model of neuroinflammation.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Brain; Drug Carriers; Encephalomyelitis, Autoimmune, Experimental; Glutathione; Liposomes; Male; Methylprednisolone; Polyethylene Glycols; Rats; Rats, Inbred Lew; Tissue Distribution | 2012 |
Methylprednisolone increases neuronal apoptosis during autoimmune CNS inflammation by inhibition of an endogenous neuroprotective pathway.
Topics: Animals; Apoptosis; Blotting, Western; Calcium; Calcium Channels; Cell Count; Cell Survival; Central Nervous System; Disease Models, Animal; Electroretinography; Encephalomyelitis, Autoimmune, Experimental; Enzyme Inhibitors; Evoked Potentials, Visual; Female; Methylprednisolone; Mitogen-Activated Protein Kinases; Myelin Proteins; Myelin-Associated Glycoprotein; Myelin-Oligodendrocyte Glycoprotein; Neurons; Optic Neuritis; Phosphorylation; Rats; Rats, Inbred BN; Retinal Ganglion Cells; Signal Transduction | 2003 |
INTRODUCTORY REMARKS: SUPPRESSION OF DEMYELINATING DISEASE.
Topics: Demyelinating Diseases; Encephalomyelitis; Encephalomyelitis, Autoimmune, Experimental; Immunosuppressive Agents; Mercaptopurine; Methotrexate; Methylprednisolone; Pharmacology | 1965 |
LARGE DOSE CORTICOSTEROID THERAPY OF EXPERIMENTAL AND HUMAN DEMYELINATING DISEASES.
Topics: Adrenal Cortex Hormones; Animals; Demyelinating Diseases; Drug Therapy; Encephalomyelitis; Encephalomyelitis, Autoimmune, Experimental; Humans; Methylprednisolone; Multiple Sclerosis; Prednisone; Rabbits | 1965 |
The therapeutic window after spinal cord injury can accommodate T cell-based vaccination and methylprednisolone in rats.
Topics: Analysis of Variance; Animals; Behavior, Animal; Cell Count; Cell Division; Cells, Cultured; Dextrans; Ectodysplasins; Encephalomyelitis, Autoimmune, Experimental; Female; Immunohistochemistry; Immunotherapy, Active; Laminectomy; Membrane Proteins; Methylprednisolone; Motor Activity; Mycobacterium; Myelin Basic Protein; Neuroprotective Agents; Peptide Fragments; Rats; Rats, Inbred Lew; Rats, Sprague-Dawley; Rhodamines; Species Specificity; Spinal Cord Injuries; T-Lymphocytes; Time Factors; Tryptophan | 2004 |
Combined therapy with methylprednisolone and erythropoietin in a model of multiple sclerosis.
Topics: Animals; Drug Therapy, Combination; Electroretinography; Encephalomyelitis, Autoimmune, Experimental; Erythropoietin; Evoked Potentials, Visual; Female; Methylprednisolone; Multiple Sclerosis; Neuroprotective Agents; Optic Nerve; Optic Neuritis; Rats; Rats, Inbred BN; Recombinant Proteins; Retinal Ganglion Cells; Signal Transduction | 2005 |
Ultrasound derived imaging and quantification of cell adhesion molecules in experimental autoimmune encephalomyelitis (EAE) by Sensitive Particle Acoustic Quantification (SPAQ).
Topics: Animals; Anti-Inflammatory Agents; Blood-Brain Barrier; Brain; Brain Chemistry; Cell Adhesion Molecules; Encephalomyelitis, Autoimmune, Experimental; Female; Image Processing, Computer-Assisted; Immunohistochemistry; Intercellular Adhesion Molecule-1; Methylprednisolone; Microspheres; Rats; Rats, Inbred Lew; Spinal Cord; Ultrasonography, Doppler, Transcranial; Vascular Cell Adhesion Molecule-1 | 2005 |
In vivo molecular imaging of adhesion molecules in experimental autoimmune encephalomyelitis (EAE).
Topics: Animals; Brain; Densitometry; Encephalomyelitis, Autoimmune, Experimental; Female; Intercellular Adhesion Molecule-1; Magnetic Resonance Imaging; Methylprednisolone; Rats; Rats, Inbred Lew; Ultrasonography | 2005 |
Liposomal glucocorticosteroids in treatment of chronic autoimmune demyelination: long-term protective effects and enhanced efficacy of methylprednisolone formulations.
Topics: Animals; Chemistry, Pharmaceutical; Encephalomyelitis, Autoimmune, Experimental; Female; Glucocorticoids; Liposomes; Methylprednisolone; Neuroprotective Agents; Rats; Rats, Inbred Lew; Time; Treatment Outcome | 2008 |
The effect of the 21-aminosteroid U74006F on the clinical course of acute experimental allergic encephalomyelitis.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Antioxidants; Disease Models, Animal; Dose-Response Relationship, Drug; Encephalomyelitis, Autoimmune, Experimental; Male; Methylprednisolone; Pregnatrienes; Rats; Rats, Inbred Lew | 1996 |
T-cell apoptosis in situ in experimental autoimmune encephalomyelitis following methylprednisolone pulse therapy.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Cells, Cultured; Chromatography, High Pressure Liquid; Encephalomyelitis, Autoimmune, Experimental; Estrogens; Female; Immunohistochemistry; Methylprednisolone; Oligodendroglia; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Inbred Lew; Spinal Cord; T-Lymphocytes | 2000 |
Interferon-beta treatment of experimental autoimmune encephalomyelitis leads to rapid nonapoptotic termination of T cell infiltration.
Topics: Animals; Apoptosis; Blood-Brain Barrier; Cells, Cultured; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Immunohistochemistry; Immunologic Factors; Interferon-beta; Macrophages; Methylprednisolone; Multiple Sclerosis, Relapsing-Remitting; Neuroprotective Agents; Rats; Rats, Inbred Lew; T-Lymphocytes; Tumor Necrosis Factor-alpha | 2001 |
Development of experimental allergic encephalomyelitis during steroid administration. Outcome of neurological immune-mediated disorders under immunosuppressive therapy.
Topics: Animals; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Incidence; Methylprednisolone; Rats; Severity of Illness Index | 1991 |
Glucosteroids in immunologically specific and nonspecific inflammatory processes.
Topics: Adrenalectomy; Animals; Arthritis; Benzene; Blood Cell Count; Brain; Carrageenan; Dermatitis, Contact; Encephalomyelitis, Autoimmune, Experimental; Freund's Adjuvant; Glucocorticoids; Graft Rejection; Hydrocortisone; Hypersensitivity, Delayed; Immunization, Secondary; Inflammation; Lymph Nodes; Lymphocyte Activation; Methylprednisolone; Metyrapone; Nerve Tissue; Rats; Skin Transplantation; Tuberculin Test; Xylenes | 1972 |
Treatment of experimental allergic encephalomyelitis in the rabbit.
Topics: Animals; Cyclophosphamide; Drug Synergism; Encephalomyelitis, Autoimmune, Experimental; Evaluation Studies as Topic; Female; Immunosuppression Therapy; Methylprednisolone; Rabbits; Time Factors | 1972 |
Prevention of experimental allergic encephalomyelitis with cobra venom factor.
Topics: Animals; Cyclophosphamide; Encephalomyelitis, Autoimmune, Experimental; Humans; Hypersensitivity, Delayed; Methylprednisolone; Multiple Sclerosis; Rabbits; Rats; Snakes; Species Specificity; Venoms | 1971 |